Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression

NCT06765603 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myopia

Interventions

DRUG: Atropine 0.025%
DEVICE: Multizonal contact lens
DRUG: Placebo
DEVICE: Single vision Contact lens

Sponsor

Singapore National Eye Centre